| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Total other income, net | 559 | 649 | 1,075 | 1,267 |
| Net loss | -7,144 | -8,561 | -11,040 | -15,176 |
| Net unrealized (loss) gain on marketable securities | -4 | -46 | -57 | 249 |
| Comprehensive loss | -7,148 | -8,607 | -11,097 | -14,927 |
| Earnings per share, basic, total | -3.72 | -4.46 | -0.29 | -0.4 |
| Earnings per share, diluted, total | -3.72 | -4.46 | -0.29 | -0.4 |
| Weighted average common shares outstanding - basic | 1,919,441 | 1,917,629 | 38,339,697 | 38,250,982 |
| Weighted-average shares outstanding, diluted | 1,919,441 | 1,917,629 | 38,339,697 | 38,250,982 |
Bolt Biotherapeutics, Inc. (BOLT)
Bolt Biotherapeutics, Inc. (BOLT)